Low-dose ouabain administration increases Na+,K+-ATPase activity and reduces cardiac force development in rats

被引:7
|
作者
Meira, Eduardo F. [1 ]
Siman, Fabiana Dayse M. [1 ]
Faria, Thais de O. [2 ]
Ribeiro Junior, Rogerio F. [2 ]
de Batista, Priscila R. [2 ]
Stefanon, Ivanita [2 ]
Vassallo, Dalton V. [3 ]
Padilha, Alessandra S. [2 ]
机构
[1] Univ Fed Espirito Santo, Ctr Ciencias Agr, Alegre, ES, Brazil
[2] Univ Fed Espirito Santo, Ctr Ciencias Saude, Vitoria, ES, Brazil
[3] EMESCAM, Escola Ensino Super Santa Casa Misericordia Vitor, Vitoria, ES, Brazil
关键词
Ouabain; Hypertension; Papillary muscles; Na+; K+-ATPase activity; SPONTANEOUSLY HYPERTENSIVE-RATS; RENIN-ANGIOTENSIN SYSTEM; VASCULAR SMOOTH-MUSCLE; NA+-K+-ATPASE; VENTRICULAR PERFORMANCE; ADRENOCORTICAL-CELLS; ENDOGENOUS OUABAIN; PRESSOR-RESPONSES; BLOOD-PRESSURE; CONTRACTILITY;
D O I
10.1016/j.pharep.2014.10.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Ouabain is a digitalis compound that inhibits the Na+,K+-ATPase (NKA) activity inducing increment in cardiac force. However, this effect seems to be dose dependent. At low concentration, ouabain can induce an increase of NKA activity. Methods: We investigated the effects of ouabain administration (25 mu g/kg/day) for 15 days on cardiac contractility and NKA activity. Blood pressure and left ventricular papillary muscle contraction from placebo and ouabain-treated rats for 15 (OUA15) days were evaluated. Isometric force, post-rest potentiation, positive inotropic intervention produced by isoproterenol, and tetanic tension were measured. The activity and protein expression levels of alpha 1 and alpha 2 isoforms of NKA, sodium calcium exchanger (NCX), sarcoplasmic reticulum calcium ATPase (SERCA2a) and phospholamban (PLB) were also measured. Results: Systolic and diastolic blood pressures increased after treatment with ouabain. However, isometric tension was reduced in the ouabain treated group. Post-rest potentiation, time parameters, inotropic interventions by isoproterenol and tetanic tension did not change. In the ouabain treated group, NKA activity was increased (Oua 406.16 +/- 70.6 vs. CT 282.80 +/- 80.5) while protein expression of the alpha 1 isoform of NKA was reduced (Oua 0.97 +/- 0.06 vs. CT 0.76 +/- 0.05). No changes were observed in protein expression of alpha 2 isoform of NKA, NCX, SERCA2a and PLB. Therefore, although 15-day ouabain treatment increases blood pressure (Oua: 116.4 +/- 3 vs. CT: 99.9 +/- 3), treatment also reduces isometric tension development (Oua: 0.34 +/- 0.14 vs. CT: 0.56 +/- 0.22). Conclusion: We suggest that the effects induced by ouabain in the isolated cardiac muscle could be related at least in part, to changes in NKA activity. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 50 条
  • [41] Evaluation of Na+, K+-ATPase activity in the brain of young rats after acute administration of fenproporex
    Rezin, Gislaine T.
    Scaini, Giselli
    Goncalves, Cinara L.
    Ferreira, Gabriela K.
    Cardoso, Mariane R.
    Ferreira, Andrea G. K.
    Cunha, Maira J.
    Schmitz, Felipe
    Varela, Roger B.
    Quevedo, Joao
    Wyse, Angela T. S.
    Streck, Emilio L.
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2014, 36 (02) : 138 - 142
  • [42] Intracerebroventricular administration of isovaleric acid reduces Na+,K+-ATPase activity and induces oxidative damage in cerebral cortex of young rats
    Ribeiro, C. A. J.
    Leipnitz, G.
    Seminotti, B.
    Amaral, A. U.
    de Bortoli, G.
    Wajner, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 18 - 18
  • [43] Increase in ouabain-sensitive K+-ATPase activity in hepatocellular carcinoma by overexpression of Na+,K+-ATPase α3-isoform
    Shibuya, Kazuto
    Fukuoka, Junya
    Fujii, Takuto
    Shimoda, Eri
    Shimizu, Takahiro
    Sakai, Hideki
    Tsukada, Kazuhiro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 638 (1-3) : 42 - 46
  • [44] Low concentrations of the Na+, K+-ATPase ligand ouabain activate intracellular signaling enzymes
    Foley, TD
    Linnoila, M
    FASEB JOURNAL, 1998, 12 (08): : A1455 - A1455
  • [45] INHIBITION OF CARDIAC NA+,K+-ATPASE ACTIVITY BY DYNORPHIN-A AND ETHYLKETOCYCLAZOCINE
    MAEDA, S
    NAKAMAE, J
    INOKI, R
    LIFE SCIENCES, 1988, 42 (04) : 461 - 468
  • [46] Na+/K+-ATPase activity in preterm infants
    B Vásárhelyi
    M Dobos
    A Nobilis
    L Zubovics
    T Machay
    T Szabo
    T Tulassay
    Pediatric Research, 1997, 42 (3) : 405 - 405
  • [47] COUPLED ASSAY OF NA+,K+-ATPASE ACTIVITY
    NORBY, JG
    METHODS IN ENZYMOLOGY, 1988, 156 : 116 - 119
  • [48] Selective decrease of Na+/K+-ATPase activity in the brain of hypothyroid rats
    Pacheco-Rosado, J
    Arias-Citalàn, G
    Ortiz-Butrón, R
    Rodríquez-Páez, L
    Proceedings of the Western Pharmacology Society, Vol 48, 2005, 48 : 52 - 54
  • [49] The effect of diazinon on Na+/K+-ATPase activity
    Krstic, D.
    Colovic, M.
    Leskovac, A.
    Vasic, V.
    TOXICOLOGY LETTERS, 2010, 196 : S324 - S325
  • [50] Intestinal Na+/K+-ATPase activity in salmonids
    Gjevre, AG
    Naess, LIM
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1996, 115 (02): : 159 - 168